LEMAITRE VASCULAR INC
LMATNASDAQ🏆 #1906 by market capEarnings Nov 5US Equity
$80.50▼ $2.27 (−2.82%)
Live1h▼ 1.2%
24h▼ 2.8%
7d▲ 2.0%
14d▼ 22.3%
30d▼ 19.6%
1y▼ 14.1%
🏦Market Cap
$1.84B
Small Cap
📈Revenue Growth (YoY)
+11.8%
Healthy
📊Gross Margin
72.9%
High
💵FCF Margin
28.1%
Strong
⚖️P/S Ratio
7.2x
Fair
Otter Score
46
Weak
📊
Analyst Ratings
Price
$80.50
Total
20
Raised
2
Lowered
3
Avg PT
$115.00
H / L
$135 / $95
| Institution | Action | Rating | Date |
|---|---|---|---|
Wells Fargo | Reiterated | Equal Weight | 2026-08-05 |
Barrington Research | Reiterated | Outperform | 2026-06-03 |
Citizens | Reiterated | Market Outperform | 2026-05-06 |
Roth Capital | Reiterated | Buy | 2026-02-26 |
Cantor Fitzgerald | Reiterated | Neutral | 2025-08-06 |
Citizens Capital Markets | Reiterated | Buy | 2025-02-28 |
Lake Street | Reiterated | Buy | 2025-02-28 |
Oppenheimer | Reiterated | Outperform | 2024-11-01 |
JMP Securities | Reiterated | Market Outperform | 2024-08-20 |
Stifel | Upgraded | Hold → Buy | 2024-04-26 |
Jefferies | Downgraded | Buy → Hold | 2023-08-03 |
KeyBanc | Reiterated | Sector Weight → Equal Weight | 2021-02-12 |
Canaccord Genuity | Reiterated | Hold | 2020-07-24 |
Sidoti & Co. | Reiterated | Buy | 2020-04-08 |
First Analysis | Downgraded | Strong Buy → Outperform | 2019-10-24 |
Benchmark | Upgraded | Hold → Buy | 2018-04-26 |
Stifel Nicolaus | Downgraded | Buy → Hold | 2018-04-26 |
Cowen & Co. | Reiterated | Outperform | 2016-04-21 |
Brean Capital | Reiterated | Buy | 2015-07-29 |
Dougherty | Reiterated | Buy | 2015-06-19 |
One row per institution, most recent rating